Comparison of the efficacy of 12 months and longer courses of interferon therapy for the treatment of chronic delta hepatitis: a retrospective cohort study

Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome

(2015) Onur Keskin et al.   Clinical Gastroenterology and Hepatology

Hepatitis D Virus: Introduction and Epidemiology

(2015) Mario Rizzetto   Cold Spring Harbor Perspectives in Medicine

Long-term therapy of chronic delta hepatitis with peginterferon alfa

(2014) T. Heller et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Invasive and non-invasive diagnosis of cirrhosis and portal hypertension

(2014) Moon Young Kim   WORLD JOURNAL OF GASTROENTEROLOGY

High genetic diversity of hepatitis delta virus in eastern Turkey

(2014) Yasemin Bulut et al.   Journal of Infection in Developing Countries

PROPEL: A randomized trial of mericitabine plus peginterferon alpha-2a/ribavirin therapy in treatment-naïve HCV genotype 1/4 patients

(2013) Heiner Wedemeyer et al.   HEPATOLOGY

Efficacy of peginterferon alpha treatment for 24 months in chronic delta hepatitis and predictors of response

(2012) Cetin Karaca et al.   ANTIVIRAL THERAPY

Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta

(2011) Heiner Wedemeyer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels

(2010) Vincent Rijckborst et al.   HEPATOLOGY

Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline

(2010) Milan J. Sonneveld et al.   HEPATOLOGY

Hepatitis D virus: an update

(2010) Stéphanie Pascarella et al.   LIVER INTERNATIONAL

A 28-Year Study of the Course of Hepatitis Δ Infection: A Risk Factor for Cirrhosis and Hepatocellular Carcinoma

(2009) Raffaella Romeo et al.   GASTROENTEROLOGY

Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

(2009) Yasuhito Tanaka et al.   NATURE GENETICS